Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.

Azenta, Inc.

Genomics Core Leuven provides services in long-read sequencing and bioinformatics analysis, focusing on technologies for data management and analysis in the fields of healthcare and biomedical research.

Genomics Core Leuven

Med-Tech Innovation Expo is a trade show and exhibition focusing on the medical device manufacturing sector, bringing together professionals from the industry.

Med-Tech Innovation Expo

Azenta Life Sciences provides sample exploration and management solutions, aimed at accelerating discovery, development, and delivery in the life sciences sector. This information is self-described.

Metric
Company Name	Azenta, Inc.	Genomics Core Leuven	Med-Tech Innovation Expo
Symbol	AZTA
MSH ID	COM:AZENTA	BE:GENOMICSCORE	COM:MED-TECHEXPO
Market	STOCKS	PRIVATE	PRIVATE
Sector	Healthcare	Healthcare & Health Services	Commercial & Professional Services
Industry	Medical - Instruments & Supplies	Biotechnology	Medical Device Manufacturing
Country	US	BE	GB
Stage
Employee Count	3.40K
Website	azenta.com	genomicscore.be	med-techexpo.com
LinkedIn			med-tech-innovation
Founders

Metric
Market Cap	2.72B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	665.07M
Revenue (LTM)
Revenue (NTM)
Gross Profit	263.14M
EBITDA	41.18M
Operating Income	-73.13M
Net Income	-14.26M
EPS	-0.22
Diluted EPS	-0.22
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.39
Operating Profit Margin	-0.11
EBITDA Margin	0.06
Net Profit Margin	-0.02
Return on Equity	-0.01
Return on Assets	-0.01
Return on Capital Employed	-0.03

COM:AZENTA

Azenta Life Sciences

Last Close

45.53

22/11 21:00

Market Cap

2.72B

Beta: -

Volume Today

4.91M

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-346.32
P/B Ratio	1.55
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	5.25
EV Multiple	455.78

Metric
Days Sales Outstanding	85.91
Days Payables Outstanding	32.51
Days Inventory Outstanding	118.96
Operating Cycle	217.62
Cash Conversion Cycle	183.35
Asset Turnover	0.28

Metric
Operating Cash Flow	17.49M
Free Cash Flow	-21.95M
Cash Flow to Debt	1.23
Operating Cash Flow/Sales	0.14
Free Cash Flow Yield	-0.01

Metric
Cash & Equivalents	310.93M
Accounts Receivable	33.99M
Inventory	115.26M
Goodwill	691.41M
Debt to Capitalization	0.03
Debt to Assets	0.02
Current Ratio	6.73
Quick Ratio	5.26

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.01
R&D to Revenue	0.05
SG&A to Revenue